BNGO
Bionano Genomics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.20
−3.23%Aug 10, 2026, 22:38 UTC
Bionano Genomics, Inc. held its Q2 2026 earnings call on August 10, 2026.
Source:Jun 24, 2026, 12:30 UTC
Bionano Genomics appointed Alex Hastie as Chief Scientific Officer, effective July 20, 2026.
Source:Jun 5, 2026, 00:00 UTC
Alka Chaubey, Ph.D. resigned as Chief Medical Officer of Bionano Genomics, Inc., effective July 5, 2026.